Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier.
TeraWatt Technology Inc., founded in 2017 and headquartered in Santa Clara, California, with a subsidiary in Tokyo, Japan, specializes in the design and development of lithium-ion rechargeable batteries. The company's focus is on creating batteries that combine high energy density, power density, and safety, catering to various electrified applications. By leveraging advanced engineering and production techniques, TeraWatt Technology aims to provide industrial clients with long-lasting, safe, and reliable power solutions, thereby enhancing the performance of their electrified systems.
Nitricity is an energy company focused on developing a system for producing carbon-free fertilizer. Utilizing its innovative technology, the company generates ready-to-use nitrogen from air, water, and renewable electricity. Nitricity produces both nitric acid and ammonia, which can be utilized individually or combined to create ammonium nitrate fertilizer. This approach aims to provide farmers with effective products that minimize wasteful runoff, allow for precise application timing, and enhance nitrogen delivery globally. Through its sustainable practices, Nitricity seeks to support agricultural efficiency and environmental stewardship.
Developer of drug discovery platform designed for radically accelerating small molecule drug discovery and finding pharmaceutical compounds for medically important targets. The company's technology rapidly analyzes compounds by combining machine learning with DNA-encoded libraries to generate enormous amounts of useful data and parallel biochemical experiments using proprietary artificial intelligence (AI) models, enabling researchers to develop new drugs.
Ultima Genomics, founded in 2016 and based in Newark, California, specializes in genome-scale sequencing technology aimed at providing analytical services to enterprises. The company employs an innovative approach using an open substrate that creates a large, low-cost reaction surface, allowing for billions of reads without the need for expensive flow cells or complex fluidics. By integrating specialized sequencing hardware with machine learning, Ultima Genomics ensures reproducible and accurate results, enabling clients to obtain genomic reports rapidly and efficiently. This technology not only enhances the scale of genomic information but also significantly reduces the costs associated with sequencing, thereby facilitating advancements in biology and improvements in human health.
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered. Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation of cellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in intracellular delivery lasers and nanotechnology specifically for gene editing applications. The company has developed an AI-guided laser editing platform that automates the generation of personalized, autologous cell therapies, significantly reducing the development time of engineered cells from years to weeks. By integrating advanced tools from optics, biology, and computation, Cellino makes stem cell differentiation a digital process, allowing healthcare providers to efficiently produce functionally mature cells at scale. This innovative approach aims to enhance the accessibility of life-saving medicines for patients.
Developer of drug discovery platform designed for radically accelerating small molecule drug discovery and finding pharmaceutical compounds for medically important targets. The company's technology rapidly analyzes compounds by combining machine learning with DNA-encoded libraries to generate enormous amounts of useful data and parallel biochemical experiments using proprietary artificial intelligence (AI) models, enabling researchers to develop new drugs.
NextVivo is a biotech company developing an immune organoid technology platform to transform the future of drug development. Its mission is to accelerate the development of safer, more effective therapies that are generated and tested in immune-competent human-derived models.
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities.Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
Encellin, Inc. is a biotechnology company based in San Francisco, California, founded in 2015. It specializes in developing innovative cell-based therapeutics, particularly focusing on a novel thin-film cell encapsulation device. This device utilizes advanced thin-film cell delivery technology, which encapsulates and replaces cells, allowing the enclosed cells to operate as smart molecular factories. Encellin's primary mission is to provide effective treatments for patients with chronic diseases, with an initial emphasis on Type 1 diabetes. The company is committed to advancing next-generation therapies through the expertise of its dedicated team.
Encellin, Inc. is a biotechnology company based in San Francisco, California, founded in 2015. It specializes in developing innovative cell-based therapeutics, particularly focusing on a novel thin-film cell encapsulation device. This device utilizes advanced thin-film cell delivery technology, which encapsulates and replaces cells, allowing the enclosed cells to operate as smart molecular factories. Encellin's primary mission is to provide effective treatments for patients with chronic diseases, with an initial emphasis on Type 1 diabetes. The company is committed to advancing next-generation therapies through the expertise of its dedicated team.
Synchron Inc., based in San Mateo, California, is a developer of advanced medical devices that facilitate brain-computer interfaces. The company specializes in an implantable stentrode, a minimally invasive device that is delivered to the brain via catheter. This device is equipped with electrode arrays that record neuron signals and interpret brain activity, allowing individuals with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies through thought alone. By bridging the gap between neural signals and device operation, Synchron aims to enhance the quality of life for patients with mobility challenges.
Apton Biosystems, Inc., founded in 2012 and based in Pleasanton, California, operates within the biotechnology sector, focusing on innovative solutions for genetic analysis. The company has developed a high-throughput and low-cost sequencing platform that enhances the availability of genetic testing, facilitating biomarker discovery, early disease detection, and therapeutic monitoring. Apton Biosystems reimagines optical systems for sequencing and single-molecule protein detection, utilizing super-resolution technology to evaluate closely spaced molecules. This approach enables the healthcare sector to create well-defined nanostructures, addressing spatial challenges and advancing high-density sequencing and protein detection capabilities. Through these advancements, Apton Biosystems contributes to the fields of preventive health and precision medicine.
Turn Biotechnologies is a Stanford spinout developing therapies to effectively return mature differentiated cells to a dramatically younger state leaving their differentiated identity unaltered. Turn Biotechnologies surpasses traditional approaches based on single gene/pathway manipulations and tackles the multifaceted manifestation of cellular age at the organ, tissue, and organismal level to extend the healthspan of people. As a result, age is reset by epigenetically reprogramming cells.
Briefcase Biotec develops KiloBaser, a Nespresso machine of DNA synthesis - enabling cutting edge research without detours. KiloBaser is a device for printing short synthetic DNA sequences. It enables individual scientists to easily produce the DNA they need on their desktops, while speeding up production of the basics for all genetic engineering and synthetic biology research and development. Headquartered in Graz, Steiermark, KiloBaser was founded in 2013 by Martin Jost and Alexander Murer.
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in intracellular delivery lasers and nanotechnology specifically for gene editing applications. The company has developed an AI-guided laser editing platform that automates the generation of personalized, autologous cell therapies, significantly reducing the development time of engineered cells from years to weeks. By integrating advanced tools from optics, biology, and computation, Cellino makes stem cell differentiation a digital process, allowing healthcare providers to efficiently produce functionally mature cells at scale. This innovative approach aims to enhance the accessibility of life-saving medicines for patients.
Advanced Chemotherapy Technologies is a healthcare company that is developing breakthrough combination drug-device technologies for treating pancreatic cancer.
HI, LLC, doing business as Kernel, a human intelligence company, develops neuro prosthesis to mimic, repair, and improve cognition. The company focuses on treating dysfunctions caused by neurodegenerative diseases. It offers a chip that can be implanted in the brain to help people suffering from neurological damage caused by strokes and Alzheimer’s/concussions. HI, LLC was founded in 2016 and is based in Los Angeles, California.
Natron Energy, Inc. is an energy storage company specializing in the development of sodium-ion batteries designed for industrial applications. Founded in 2012 and based in Santa Clara, California, the company focuses on delivering high power, long cycle life, and cost-effective battery solutions. Its products utilize a unique Prussian blue chemistry, making them suitable for a range of applications, including uninterruptible power supplies, lift trucks, renewable energy smoothing, smart grids, and electric vehicle fast charging. Natron Energy aims to provide efficient energy storage systems that can be economically produced using readily available materials and existing manufacturing processes, thus enhancing the performance and lifespan of batteries while maintaining low operating costs.
Menten AI, Inc. is an early-stage drug discovery company based in San Francisco, California, with an additional location in Toronto, Canada. Founded in 2018, the company focuses on developing protein-based drugs and enzymes using advanced technologies, specifically machine learning and quantum computing. Menten AI addresses the complex challenge of designing proteins, which can adopt numerous shapes, by leveraging quantum computing to represent multiple protein states simultaneously. This innovative approach allows for more efficient identification of optimal protein designs. The company has achieved significant milestones, including creating the world’s first peptide designed on a quantum computer, and is currently working on peptide therapeutics aimed at treating oncology and neurodegeneration, as well as enzymes for various industrial applications.
Genalyte, Inc. is a clinical and diagnostic life science company based in San Diego, California, specializing in rapid diagnostic testing solutions. Founded in 2007, Genalyte has developed an innovative technology platform that utilizes silicon photonic biosensors to quantify biomolecular interactions, such as those between antibodies and proteins. This platform, known as the Maverick, allows for the direct measurement of protein binding and nucleic acid hybridization. Genalyte's technology is employed by healthcare providers, pharmaceutical companies, and academic researchers to monitor autoimmune diseases, screen for cancer biomarkers, detect anti-drug antibodies, and test for infectious agents, including Ebola. The company aims to enhance patient care by enabling rapid diagnostics, with tests typically completed in under thirty minutes, and providing mobile laboratory solutions for real-time diagnostics.
Encellin, Inc. is a biotechnology company based in San Francisco, California, founded in 2015. It specializes in developing innovative cell-based therapeutics, particularly focusing on a novel thin-film cell encapsulation device. This device utilizes advanced thin-film cell delivery technology, which encapsulates and replaces cells, allowing the enclosed cells to operate as smart molecular factories. Encellin's primary mission is to provide effective treatments for patients with chronic diseases, with an initial emphasis on Type 1 diabetes. The company is committed to advancing next-generation therapies through the expertise of its dedicated team.
Bionaut Labs is a biotechnology company that specializes in developing an intra-tissue navigation platform using nano and micro-robots for medical applications. Founded in 2016 and headquartered in California, Bionaut Labs focuses on creating a delivery mechanism that allows for anatomically precise navigation within the body. The company's innovative micro-robotic technology is designed to access any anatomical location, enabling medical professionals to perform complex surgical procedures remotely and without external incisions. This advancement is achieved through an advanced remote control and imaging system that accurately guides the robots to their targets, monitors their progress, and triggers the release of therapeutic payloads at the appropriate locations and times.
Cellino Biotech, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2017. It specializes in intracellular delivery lasers and nanotechnology specifically for gene editing applications. The company has developed an AI-guided laser editing platform that automates the generation of personalized, autologous cell therapies, significantly reducing the development time of engineered cells from years to weeks. By integrating advanced tools from optics, biology, and computation, Cellino makes stem cell differentiation a digital process, allowing healthcare providers to efficiently produce functionally mature cells at scale. This innovative approach aims to enhance the accessibility of life-saving medicines for patients.
Prellis Biologics is building human tissues for drug development, and ultimately, developing human organs for transplantation. Bioprinting vascularized human tissue and organs will revolutionize healthcare. Prellis Biologics' technology leverages massive gains in print speed and resolution to break the microvasculature barrier.
Rocket Lab Ltd. specializes in designing and manufacturing rocket and space systems, focusing on low-cost and efficient payload deployment. Founded in 2006 and based in Auckland, New Zealand, the company offers a variety of technologies, including carbon composite materials, thermal protection products, recovery systems, propulsion systems, and electronic systems for avionics and communication. Its flagship orbital launch vehicle, Electron, aims to transform the space industry by providing dedicated, high-frequency launches tailored for the growing small satellite market. Rocket Lab's innovations are geared towards making space access more affordable and accessible.
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes (proteins, viruses, antibodies, etc) from any life form. Use in human and animal diagnostics, agriculture, food safety testing, environmental monitoring, and more. Our platforms use silicon nanopore chips and proprietary biochemistry to accurately detect and differentiate single molecules. We will help transform point-of-care testing and third generation sequencing.
Rocket Lab Ltd. specializes in designing and manufacturing rocket and space systems, focusing on low-cost and efficient payload deployment. Founded in 2006 and based in Auckland, New Zealand, the company offers a variety of technologies, including carbon composite materials, thermal protection products, recovery systems, propulsion systems, and electronic systems for avionics and communication. Its flagship orbital launch vehicle, Electron, aims to transform the space industry by providing dedicated, high-frequency launches tailored for the growing small satellite market. Rocket Lab's innovations are geared towards making space access more affordable and accessible.
Genalyte, Inc. is a clinical and diagnostic life science company based in San Diego, California, specializing in rapid diagnostic testing solutions. Founded in 2007, Genalyte has developed an innovative technology platform that utilizes silicon photonic biosensors to quantify biomolecular interactions, such as those between antibodies and proteins. This platform, known as the Maverick, allows for the direct measurement of protein binding and nucleic acid hybridization. Genalyte's technology is employed by healthcare providers, pharmaceutical companies, and academic researchers to monitor autoimmune diseases, screen for cancer biomarkers, detect anti-drug antibodies, and test for infectious agents, including Ebola. The company aims to enhance patient care by enabling rapid diagnostics, with tests typically completed in under thirty minutes, and providing mobile laboratory solutions for real-time diagnostics.
Thync, Inc. is a technology company based in Los Gatos, California, established in 2011. It specializes in developing wearable devices that utilize neurosignaling to help users shift their mental states, such as enhancing energy, calmness, or focus. Founded by experts in neurobiology and consumer electronics, Thync's products aim to provide on-demand transitions in mental states through innovative technology. The company's bioelectronic products also seek to address mental health challenges and enhance overall well-being by targeting autonomic pathways that play a crucial role in various health conditions. Through its focus on neurostimulation, Thync enables users to improve their mental state and energy levels effectively.
Rocket Lab Ltd. specializes in designing and manufacturing rocket and space systems, focusing on low-cost and efficient payload deployment. Founded in 2006 and based in Auckland, New Zealand, the company offers a variety of technologies, including carbon composite materials, thermal protection products, recovery systems, propulsion systems, and electronic systems for avionics and communication. Its flagship orbital launch vehicle, Electron, aims to transform the space industry by providing dedicated, high-frequency launches tailored for the growing small satellite market. Rocket Lab's innovations are geared towards making space access more affordable and accessible.
Genalyte, Inc. is a clinical and diagnostic life science company based in San Diego, California, specializing in rapid diagnostic testing solutions. Founded in 2007, Genalyte has developed an innovative technology platform that utilizes silicon photonic biosensors to quantify biomolecular interactions, such as those between antibodies and proteins. This platform, known as the Maverick, allows for the direct measurement of protein binding and nucleic acid hybridization. Genalyte's technology is employed by healthcare providers, pharmaceutical companies, and academic researchers to monitor autoimmune diseases, screen for cancer biomarkers, detect anti-drug antibodies, and test for infectious agents, including Ebola. The company aims to enhance patient care by enabling rapid diagnostics, with tests typically completed in under thirty minutes, and providing mobile laboratory solutions for real-time diagnostics.
Genalyte, Inc. is a clinical and diagnostic life science company based in San Diego, California, specializing in rapid diagnostic testing solutions. Founded in 2007, Genalyte has developed an innovative technology platform that utilizes silicon photonic biosensors to quantify biomolecular interactions, such as those between antibodies and proteins. This platform, known as the Maverick, allows for the direct measurement of protein binding and nucleic acid hybridization. Genalyte's technology is employed by healthcare providers, pharmaceutical companies, and academic researchers to monitor autoimmune diseases, screen for cancer biomarkers, detect anti-drug antibodies, and test for infectious agents, including Ebola. The company aims to enhance patient care by enabling rapid diagnostics, with tests typically completed in under thirty minutes, and providing mobile laboratory solutions for real-time diagnostics.
Atomwise, Inc. specializes in deep learning artificial intelligence technology aimed at small molecule drug discovery. The company leverages its proprietary AI platform, AtomNet, which contains over 16 billion molecules for virtual screening, to enhance the speed and accuracy of drug discovery processes. This technology employs a statistical approach to predict the binding of small molecules to proteins, aiding in drug hit discovery, binding affinity prediction, and toxicity detection. Atomwise collaborates on numerous projects each year with major pharmaceutical and agrochemical companies, as well as over 200 universities and hospitals across 40 countries. Founded in 2012 and based in San Francisco, Atomwise was previously known as Chematria, Inc. before rebranding in 2015.
20n Labs, Inc. is a biotechnology company based in Berkeley, California, that specializes in the development of synthetic microbes through advanced algorithms. Founded in 2013, the company focuses on engineering microbes to produce valuable chemicals for health and industrial applications. Notably, 20n has developed a bacteria capable of producing paracetamol, demonstrating a unique method of generating this widely used analgesic that does not exist in nature. The company is also creating a data mining platform that aims to facilitate the bioproduction of a diverse range of molecules, allowing researchers to design custom fermentation organisms and predict DNA edits in synthetic biology. This innovative approach positions 20n as a leader in leveraging technology to advance biotechnological solutions.
Apton Biosystems, Inc., founded in 2012 and based in Pleasanton, California, operates within the biotechnology sector, focusing on innovative solutions for genetic analysis. The company has developed a high-throughput and low-cost sequencing platform that enhances the availability of genetic testing, facilitating biomarker discovery, early disease detection, and therapeutic monitoring. Apton Biosystems reimagines optical systems for sequencing and single-molecule protein detection, utilizing super-resolution technology to evaluate closely spaced molecules. This approach enables the healthcare sector to create well-defined nanostructures, addressing spatial challenges and advancing high-density sequencing and protein detection capabilities. Through these advancements, Apton Biosystems contributes to the fields of preventive health and precision medicine.
Arcanum Alloys is a technology-driven company based in Sunnyvale, California, that specializes in the development and manufacturing of advanced steel alloys. Incorporated in 2011, the company focuses on creating innovative metal alloys for various industries, including appliances, home goods, and architecture. By integrating technologies from high-tech sectors, Arcanum aims to redefine traditional metallurgical processes, which have remained largely unchanged for over a century. Their proprietary methods utilize spatial segregation of metallurgical elements, resulting in alloyed products that offer enhanced performance, lower manufacturing costs, and reduced lead times compared to existing materials. This approach not only improves product functionality but also minimizes overall supply-chain costs and energy consumption, ultimately benefiting customers across different sectors.
Rocket Lab Ltd. specializes in designing and manufacturing rocket and space systems, focusing on low-cost and efficient payload deployment. Founded in 2006 and based in Auckland, New Zealand, the company offers a variety of technologies, including carbon composite materials, thermal protection products, recovery systems, propulsion systems, and electronic systems for avionics and communication. Its flagship orbital launch vehicle, Electron, aims to transform the space industry by providing dedicated, high-frequency launches tailored for the growing small satellite market. Rocket Lab's innovations are geared towards making space access more affordable and accessible.
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.
Thync, Inc. is a technology company based in Los Gatos, California, established in 2011. It specializes in developing wearable devices that utilize neurosignaling to help users shift their mental states, such as enhancing energy, calmness, or focus. Founded by experts in neurobiology and consumer electronics, Thync's products aim to provide on-demand transitions in mental states through innovative technology. The company's bioelectronic products also seek to address mental health challenges and enhance overall well-being by targeting autonomic pathways that play a crucial role in various health conditions. Through its focus on neurostimulation, Thync enables users to improve their mental state and energy levels effectively.
Centipede Semiconductor is a privately held intellectual property provider that specializes in advanced high-end processors. The company focuses on delivering innovative technology that enhances the performance and capabilities of digital products. By granting customers significant control over the technology embedded within their processors, Centipede aims to improve existing architectural solutions. Its advancements are positioned to impact multi-billion dollar markets, reflecting the company's commitment to driving progress in semiconductor technology.
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.
Rocket Lab Ltd. specializes in designing and manufacturing rocket and space systems, focusing on low-cost and efficient payload deployment. Founded in 2006 and based in Auckland, New Zealand, the company offers a variety of technologies, including carbon composite materials, thermal protection products, recovery systems, propulsion systems, and electronic systems for avionics and communication. Its flagship orbital launch vehicle, Electron, aims to transform the space industry by providing dedicated, high-frequency launches tailored for the growing small satellite market. Rocket Lab's innovations are geared towards making space access more affordable and accessible.
Consumer Physics Inc., based in Tel Aviv, Israel, specializes in the development and distribution of molecular sensors under the SCiO brand. Since its incorporation in 2011, the company has focused on empowering consumers and businesses to analyze the composition of materials using its compact near-infrared spectrometer. The SCiO device connects to smartphone applications and a cloud-based database of material fingerprints, allowing users to access real-time material analysis. Additionally, Consumer Physics provides a platform for businesses and third-party developers to create customized molecular sensing models and mobile applications, facilitating data-driven decisions that can help reduce food waste and enhance operational efficiency in industries such as food and agriculture. The SCiO DevKit offers developers the necessary tools and support to innovate in this area.
Natron Energy, Inc. is an energy storage company specializing in the development of sodium-ion batteries designed for industrial applications. Founded in 2012 and based in Santa Clara, California, the company focuses on delivering high power, long cycle life, and cost-effective battery solutions. Its products utilize a unique Prussian blue chemistry, making them suitable for a range of applications, including uninterruptible power supplies, lift trucks, renewable energy smoothing, smart grids, and electric vehicle fast charging. Natron Energy aims to provide efficient energy storage systems that can be economically produced using readily available materials and existing manufacturing processes, thus enhancing the performance and lifespan of batteries while maintaining low operating costs.
Consumer Physics Inc., based in Tel Aviv, Israel, specializes in the development and distribution of molecular sensors under the SCiO brand. Since its incorporation in 2011, the company has focused on empowering consumers and businesses to analyze the composition of materials using its compact near-infrared spectrometer. The SCiO device connects to smartphone applications and a cloud-based database of material fingerprints, allowing users to access real-time material analysis. Additionally, Consumer Physics provides a platform for businesses and third-party developers to create customized molecular sensing models and mobile applications, facilitating data-driven decisions that can help reduce food waste and enhance operational efficiency in industries such as food and agriculture. The SCiO DevKit offers developers the necessary tools and support to innovate in this area.
Arcanum Alloys is a technology-driven company based in Sunnyvale, California, that specializes in the development and manufacturing of advanced steel alloys. Incorporated in 2011, the company focuses on creating innovative metal alloys for various industries, including appliances, home goods, and architecture. By integrating technologies from high-tech sectors, Arcanum aims to redefine traditional metallurgical processes, which have remained largely unchanged for over a century. Their proprietary methods utilize spatial segregation of metallurgical elements, resulting in alloyed products that offer enhanced performance, lower manufacturing costs, and reduced lead times compared to existing materials. This approach not only improves product functionality but also minimizes overall supply-chain costs and energy consumption, ultimately benefiting customers across different sectors.
Sand 9, Inc. is a venture-funded startup focused on designing microelectromechanical systems (MEMS) that enhance the performance and capabilities of wireless devices. The company specializes in piezoelectric MEMS products that serve both wireless and wired systems across various markets, including communications, industrial, military, and mobile applications. By developing advanced timing components, Sand 9 aims to address the growing demands for improved functionality in modern communication infrastructure and low-power wireless technologies.
NanoH2O specializes in the manufacturing of advanced reverse osmosis membranes designed for water desalination and reuse. The company enhances traditional polymer-based membranes with a nano-structured material, which allows for improved control over essential membrane properties. This innovation results in membranes that exhibit higher throughput while maintaining effective salt and contaminant rejection levels. Additionally, the membranes offer resistance to both passive and active fouling, making them suitable for various water chemistries. NanoH2O's products are aimed at reducing the costs associated with desalination processes and enhancing energy efficiency and productivity in seawater, brackish water, and wastewater reclamation applications.
Private Equity Round in 2012
Nu-Tek Food Science, LLC specializes in developing sodium replacement products aimed at reducing sodium intake in food. The company offers NuTek Salt, which replaces sodium with potassium, and Salt for Life, a blend of potassium salt and sea salt designed for culinary use. These products leverage patented technology and improved potassium chloride to enhance flavor while lowering sodium levels, catering to the needs of food manufacturers, retailers, and restaurant chains. Founded in 2006 and headquartered in Minnetonka, Minnesota, Nu-Tek also has offices in Omaha, Minneapolis, and Washington, D.C., alongside a manufacturing facility in Fargo, North Dakota.
NanoH2O specializes in the manufacturing of advanced reverse osmosis membranes designed for water desalination and reuse. The company enhances traditional polymer-based membranes with a nano-structured material, which allows for improved control over essential membrane properties. This innovation results in membranes that exhibit higher throughput while maintaining effective salt and contaminant rejection levels. Additionally, the membranes offer resistance to both passive and active fouling, making them suitable for various water chemistries. NanoH2O's products are aimed at reducing the costs associated with desalination processes and enhancing energy efficiency and productivity in seawater, brackish water, and wastewater reclamation applications.
Soraa is a cleantech startup that specializes in advanced LED technology and lasers, with a focus on creating high-quality, energy-efficient lighting solutions. The company has developed proprietary LED technology that utilizes pure gallium nitride substrates to deliver full spectrum color rendering, which mimics natural light. By prioritizing the impact of light on well-being, productivity, and emotion, Soraa aims to enhance the human experience through illumination. The company conducts extensive research to innovate and improve its products, ensuring that its lighting solutions not only serve functional purposes but also enrich the environments they illuminate. Through its commitment to scientific advancement, Soraa seeks to transform indoor lighting into an experience that resonates with users.
Danotek Motion Technologies Inc, founded in 2001, in Ann Arbor, Michigan is an ISO 9001:2000 certified technology innovator. Danotek develops clean, energy efficient, generators, electrical conversion systems, brushless motors and electronics controls for alternative energy and advanced transportation applications. Danotek has developed a number of patent-pending innovative products that include variable speed permanent magnet (PM) generators and brushless motors with integrated electronics for wind power, fuel cell, CHP, auxiliary power and electric and hybrid electric vehicles. Their designs represent industry leadership and are expected to replace inefficient and unreliable systems with added extensive control features.
Arcanum Alloys is a technology-driven company based in Sunnyvale, California, that specializes in the development and manufacturing of advanced steel alloys. Incorporated in 2011, the company focuses on creating innovative metal alloys for various industries, including appliances, home goods, and architecture. By integrating technologies from high-tech sectors, Arcanum aims to redefine traditional metallurgical processes, which have remained largely unchanged for over a century. Their proprietary methods utilize spatial segregation of metallurgical elements, resulting in alloyed products that offer enhanced performance, lower manufacturing costs, and reduced lead times compared to existing materials. This approach not only improves product functionality but also minimizes overall supply-chain costs and energy consumption, ultimately benefiting customers across different sectors.
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.
Sand 9, Inc. is a venture-funded startup focused on designing microelectromechanical systems (MEMS) that enhance the performance and capabilities of wireless devices. The company specializes in piezoelectric MEMS products that serve both wireless and wired systems across various markets, including communications, industrial, military, and mobile applications. By developing advanced timing components, Sand 9 aims to address the growing demands for improved functionality in modern communication infrastructure and low-power wireless technologies.
Nordic’s N1000, a simple, light-weight 1MW wind turbine is known for its unsurpassed ease of installation and maintenance, exceptional reliability, and low cost of energy generation. Nordic Windpower is a technology developer and manufacturer of innovative, two-bladed wind turbines for the rapidly expanding global wind market.
Danotek Motion Technologies Inc, founded in 2001, in Ann Arbor, Michigan is an ISO 9001:2000 certified technology innovator. Danotek develops clean, energy efficient, generators, electrical conversion systems, brushless motors and electronics controls for alternative energy and advanced transportation applications. Danotek has developed a number of patent-pending innovative products that include variable speed permanent magnet (PM) generators and brushless motors with integrated electronics for wind power, fuel cell, CHP, auxiliary power and electric and hybrid electric vehicles. Their designs represent industry leadership and are expected to replace inefficient and unreliable systems with added extensive control features.
Sand 9, Inc. is a venture-funded startup focused on designing microelectromechanical systems (MEMS) that enhance the performance and capabilities of wireless devices. The company specializes in piezoelectric MEMS products that serve both wireless and wired systems across various markets, including communications, industrial, military, and mobile applications. By developing advanced timing components, Sand 9 aims to address the growing demands for improved functionality in modern communication infrastructure and low-power wireless technologies.
Nanostellar, Inc. develops precious-metals containing materials for the automotive and stationary power industries, enabling these industries to meet stringent diesel emissions-control requirements mandated in Europe, the U.S. and Asia. The company delivers nano-engineered catalyst materials that reduce exhaust emissions and increase effectiveness of precious metals in these catalysts by 25%-30%. Nanostellar's Rational Catalyst Design methodology combines computation materials science, novel synthesis and chemical engineering to aid in the rapid development of new materials.
Soraa is a cleantech startup that specializes in advanced LED technology and lasers, with a focus on creating high-quality, energy-efficient lighting solutions. The company has developed proprietary LED technology that utilizes pure gallium nitride substrates to deliver full spectrum color rendering, which mimics natural light. By prioritizing the impact of light on well-being, productivity, and emotion, Soraa aims to enhance the human experience through illumination. The company conducts extensive research to innovate and improve its products, ensuring that its lighting solutions not only serve functional purposes but also enrich the environments they illuminate. Through its commitment to scientific advancement, Soraa seeks to transform indoor lighting into an experience that resonates with users.
NanoH2O specializes in the manufacturing of advanced reverse osmosis membranes designed for water desalination and reuse. The company enhances traditional polymer-based membranes with a nano-structured material, which allows for improved control over essential membrane properties. This innovation results in membranes that exhibit higher throughput while maintaining effective salt and contaminant rejection levels. Additionally, the membranes offer resistance to both passive and active fouling, making them suitable for various water chemistries. NanoH2O's products are aimed at reducing the costs associated with desalination processes and enhancing energy efficiency and productivity in seawater, brackish water, and wastewater reclamation applications.
Sand 9, Inc. is a venture-funded startup focused on designing microelectromechanical systems (MEMS) that enhance the performance and capabilities of wireless devices. The company specializes in piezoelectric MEMS products that serve both wireless and wired systems across various markets, including communications, industrial, military, and mobile applications. By developing advanced timing components, Sand 9 aims to address the growing demands for improved functionality in modern communication infrastructure and low-power wireless technologies.
LanzaTech, Inc. is a carbon recycling company based in Skokie, Illinois, with additional offices in Roselle, Illinois; Shanghai, China; and Gurgaon, India. Founded in 2005, the company specializes in producing fuel ethanol from renewable non-food resources, including industrial flue gases and waste gases generated from the gasification of municipal solid waste and biomass. LanzaTech's innovative technology enables the conversion of carbon emissions from sources like steel mills into valuable products, such as sustainable fuels and chemicals, thus contributing to a circular carbon economy. By recycling carbon from various waste streams, LanzaTech aims to reduce global CO2 emissions significantly and displace a substantial portion of crude oil use, ultimately transforming waste carbon into essential building blocks for consumer goods.
Codon Devices
Series B in 2006
Codon Devices is a biotechnology company, engages in developing, constructing, and delivering synthetic biology products for research. The company focuses on discovering and manufacturing synthetic biological parts. Its BioLOGIC Engineering Platform combines sophisticated design algorithms with assay and protein engineering capabilities to result in a system for the design, discovery, and optimization of proteins for specific applications; and BioFAB Production Platform, which produces synthetic genes.
Nanostellar, Inc. develops precious-metals containing materials for the automotive and stationary power industries, enabling these industries to meet stringent diesel emissions-control requirements mandated in Europe, the U.S. and Asia. The company delivers nano-engineered catalyst materials that reduce exhaust emissions and increase effectiveness of precious metals in these catalysts by 25%-30%. Nanostellar's Rational Catalyst Design methodology combines computation materials science, novel synthesis and chemical engineering to aid in the rapid development of new materials.